Skip to content
Home/Companies/Biotech/Integra Therapeutics
Integra Therapeutics

Integra Therapeutics

Biotech·Spain·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Integra Therapeutics?

Integra Therapeutics is currently owned by Columbus Venture Partners through Columbus Life Sciences Fund III (2021 vintage), since 2022. Across its history, Integra Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Columbus Venture Partners
Most recent investor
Columbus Venture Partners
Columbus Life Sciences Fund III · 2021 · Life Sciences VC
3 ownership periods · full history below

Key facts

HQFrance
SectorBiotech

Ownership history

3 ownership periods · co-invest detected

Active
Co-invest · 3 holders · 2021 · present
Invivo Partners
2021 · present(5yr) · Invivo Ventures · 2019 · Life Sciences VC
AdBio Partners
2021 · present(5yr) · AFB Fund II · 2021 · VC
Columbus Venture Partners
2022 · present(4yr) · Columbus Life Sciences Fund III · 2021 · Life Sciences VC

More from Columbus Life Sciences Fund III

Other portfolio companies in the same fund.

Track Integra Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Integra Therapeutics?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Integra Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue